References
- Price M, Ballard C, Benedetti J, Neff C, Cioffi G, Waite KA, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2017-2021. Neuro Oncol 2024; 26(Suppl 6): vi1–85. doi: 10.1093/neuonc/noae145
- Blumenthal DT, Won M, Mehta MP, Gilbert MR, Brown PD, Bokstein F, et al. Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group database. Neuro Oncol 2018; 20: 966-74. doi: 10.1093/neuonc/noy017
- Waqar M, Trifiletti DM, McBain C, O’Connor J, Coope DJ, Akkari L, et al. Early therapeutic interventions for newly diagnosed glioblastoma: rationale and review of the literature. Curr Oncol Rep 2022; 24: 311-24. doi: 10.1007/s11912-021-01157-0
- Buszek SM, Al Feghali KA, Elhalawani H, Chevli N, Allen PK, Chung C. Optimal timing of radiotherapy following gross total or subtotal resection of glioblastoma: a real-world assessment using the National Cancer Database. Sci Rep 2020; 10: 4926. doi: 10.1038/s41598-020-61701-z.
- Zur I, Tzuk-Shina T, Guriel M, Eran A, Kaidar-Person O. Survival impact of the time gap between surgery and chemo-radiotherapy in Glioblastoma patients. Sci Rep 2020; 10: 9595. doi: 10.1038/s41598-020-66608-3.
- Li YM, Suki D, Hess K, Sawaya R. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection? J Neurosurg 2016; 124: 977-88. doi: 10.3171/2015.5.JNS142087
- Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 987-96. doi: 10.1056/NEJMoa043330
- Wen PY, van den Bent M, Youssef G, Cloughesy TF, Ellingson BM, Weller M, et al. RANO 2.0: Update to the response assessment in neuro-oncology criteria for high-and low-grade gliomas in adults. J Clin Oncol 2023; 41: 5187-99. doi: 10.1200/JCO.23.01059
- Burnet NG, Jena R, Jefferies SJ, Stenning SP, Kirkby NF. Mathematical modelling of survival of glioblastoma patients suggests a role for radiotherapy dose escalation and predicts poorer outcome after delay to start treatment. Clin Oncol (R Coll Radiol) 2006; 18: 93-103. doi: 10.1016/j.clon.2005.08.017
- Irwin C, Hunn M, Purdie G, Hamilton D. Delay in radiotherapy shortens survival in patients with high grade glioma. J Neurooncol 2007; 85: 339-43. doi: 10.1007/s11060-007-9426-z.
- Blumenthal DT, Won M, Mehta MP, Curran WJ, Souhami L, Michalski JM, et al. Short delay in initiation of radiotherapy may not affect outcome of patients with glioblastoma: a secondary analysis from the radiation therapy oncology group database. J Clin Oncol 2009; 27: 733-9. doi: 10.1200/JCO.2008.18.9035.
- Nathan JK, Brezzell AL, Kim MM, Leung D, Wilkinson DA, Hervey-Jumper SL. Early initiation of chemoradiation following index craniotomy is associated with decreased survival in high-grade glioma. J Neurooncol 2017; 135: 325-33. doi: 10.1007/s11060-017-2577-7
- Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 2021; 23: 1231-51. doi: 10.1093/neuonc/noab106
- Sharma M, McKenzie GW, Gaskins J, Yusuf M, Woo S, Mistry AM, et al. Demographic variations and time to initiation of adjunct treatment following surgical resection of anaplastic astrocytoma in the United States: a National Cancer Database analysis. J Neurooncol 2023; 162: 199-210. doi: 10.1007/s11060-023-04286-7
- Zhang M, Xu F, Ni W, Qi W, Cao W, Xu C, et al. Survival impact of delaying postoperative chemoradiotherapy in newly-diagnosed glioblastoma patients. Transl Cancer Res 2020; 9: 5450-8. doi: 10.21037/tcr-20-1119
- Sun MZ, Oh T, Ivan ME, Clark AJ, Safaee M, Sayegh ET, et al. Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma. J Neurosurg 2015; 122: 1144-50. doi: 10.3171/2014.9.JNS14193
- Press RH, Shafer SL, Jiang R, Buchwald ZS, Abugideiri M, Tian S, et al. Optimal timing of chemoradiotherapy after surgical resection of glioblastoma: stratification by validated prognostic classification. Cancer 2020; 126: 3255-64. doi: 10.1002/cncr.32797.
- Noel G, Huchet A, Feuvret L, Maire JP, Verrelle P, Le Rhun E, et al. Waiting times before initiation of radiotherapy might not affect outcomes for patients with glioblastoma: a French retrospective analysis of patients treated in the era of concomitant temozolomide and radiotherapy. J Neurooncol 2012; 109: 167-75. doi: 10.1007/s11060-012-0883-7.
- Loureiro LVM, Pontes Lde B, Callegaro-Filho D, Koch Lde O, Weltman E, Victor Eda S, et al. Waiting time to radiotherapy as a prognostic factor for glioblastoma patients in a scenario of medical disparities. Arq Neuropsiquiatr 2015; 73: 104-10. doi: 10.1590/0004-282X20140202
- Wang TJC, Jani A, Estrada JP, Ung TH, Chow DS, Soun JE, et al. Timing of adjuvant radiotherapy in glioblastoma patients: a single-institution experience with more than 400 patients. Neurosurgery 2016; 78: 676-82. doi: 10.1227/NEU.0000000000001036
- Katsigiannis S, Krischek B, Barleanu S, Grau S, Galldiks N, Timmer M, et al. Impact of time to initiation of radiotherapy on survival after resection of newly diagnosed glioblastoma. Radiat Oncol 2019; 14: 73. doi: 10.1186/s13014-019-1272-6.
- Ahn S, Park JS, Song JH, Jeun SS, Hong YK. Effect of a time delay for concomitant chemoradiation after surgery for newly diagnosed glioblastoma: A single-institution study with subgroup analysis according to the extent of tumor resection. World Neurosurg 2020; 133: e640–5. doi: 10.1016/j.wneu.2019.09.122
- Domènech M, Hernández A, Plaja A, Martínez-Balibrea E, Balañà C. Hypoxia: The cornerstone of glioblastoma. Int J Mol Sci 2021; 22: 12608. doi: 10.3390/ijms222212245
- Murray D, Mirzayans R, Scott AL, Allalunis-Turner MJ. Influence of oxygen on the radiosensitivity of human glioma cell lines. Am J Clin Oncol 2003; 26: e169-77. doi: 10.1097/01.coc.0000091359.11281.f4
- Atalar B, Choi CYH, Harsh GR, Chang SD, Gibbs IC, Adler JR, et al. Cavity volume dynamics after resection of brain metastases and timing of postresection cavity stereotactic radiosurgery. Neurosurgery 2013; 72: 180-5; discussion 185. doi: 10.1227/NEU.0b013e31827b99f3
- Champ CE, Siglin J, Mishra M V, Shen X, Werner-Wasik M, Andrews DW, et al. Evaluating changes in radiation treatment volumes from post-operative to same-day planning MRI in High-grade gliomas. Radiat Oncol 2012; 7: 220. doi: 10.1186/1748-717x-7-220.
- Peker S, Abacioglu U, Sun I, Yuksel M, Pamir MN. Irradiation after surgically induced brain injury in the rat: timing in relation to severity of radiation damage. J Neurooncol 2004; 70: 17-21. doi: 10.1023/b:neon.0000040820.78643.0a
- Randolph DM, McTyre ER, Paulsson AK, Holmes JA, Hinson WH, Lesser GJ, et al. Impact of timing of radiotherapy in patients with newly diagnosed glioblastoma. Clin Neurol Neurosurg 2016; 151: 73-8. doi: 10.1016/j.clineuro.2016.10.012
- Gállego Pérez-Larraya J, Ducray F. Treating glioblastoma patients with poor performance status: where do we go from here? CNS Oncol 2014; 3: 231-41. doi: 10.2217/cns.14.20. Erratum in: CNS Oncol 2014; 3: 378. doi:10.2217/cns.14.20